Showing results (21-30 of 229) with videos related to

Sort By:
Pageof 23
International Journal of Clinical Pharmacology Research|January 1, 1990
Acetyl-L-carnitine in the treatment of mildly demented elderly patientsM Passeri, D Cucinotta, P A Bonati, et al.
Gerontology|January 1, 1997
Diagnosing Alzheimer's disease in very elderly patients. Relevance of some functional and psychobehavioral aspects assessed by the Gottfries-Bråne-Steen Rating Scale for Dementia. Study Group on Brain Aging, Italian Society of Gerontology and GeriatricsL Parnetti, J O Brooks, M Pippi, et al.
Neuroscience Letters|August 1, 1997
Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patientsB Palumbo, L Parnetti, G Nocentini, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1990
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer typeL Parnetti, P Mecocci, A Gaiti, et al.
Neuroscience Letters|January 2, 1995
Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementiaL Parnetti, B Palumbo, L Cardinali, et al.
Pharmacological Research Communications|May 1, 1986
Long term-effect of fenofibrate on lipoprotein level and composition in different types of genetic hyperlipidemiasG Baggio, A Gasparotto, G Ciuffetti, et al.
Minerva Medica|November 1, 1989
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]G Ciuffetti, M Mercuri, R Lombardini, et al.
Thrombosis and Haemostasis|February 1, 1996
Hemostasis abnormalities in patients with vascular dementia and Alzheimer's diseaseD Mari, L Parnetti, R Coppola, et al.
Archives of Gerontology and Geriatrics|September 1, 1995
Dexamethasone suppression test in elderly patients with dementia of Alzheimer type, vascular dementia and stroke: a re-evaluation of its applicabilityL Parnetti, G Reboldi, C Santucci, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 1991
Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical studyU Senin, G Abate, C Fieschi, et al.
Pageof 23